Survivin Urine mRNA Assay Risk of Bladder Cancer Study
NCT00315653
·
clinicaltrials.gov ↗
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class
Conditions
Bladder Cancer
Sponsor
Fujirebio Diagnostics, Inc.